The experimental frameworks presented herein and elsewhere (12) should be valuable for understanding the biochemical effects of pathological mutations, such as those associated with early onset breast and ovarian cancer risk (18,19) or with XX-GD (20), in the Hop2-Mnd1 complex. The gene discussed is PSMC3IP; the disease is ovarian carcinoma.